Drawing for HISTOGENEX

USPTO serial 87315906

HISTOGENEX

Reviewed by CopyMark Law Group

Reg. 5566528Status 710
Filing date
Status date
Registration date
Sep 18, 2018
Examiner
FLETCHER, TRACY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with HISTOGENEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin W. Schiffmiller

MARTIN W. SCHIFFMILLER KIRSCHSTEIN ISRAEL SCHIFFMILLER & PIERONI, P.C.425 FIFTH AVENUE, 5TH FLOORNEW YORK, NY 10016-2223UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical research and clinical trials and tests, research data and medical data; providing independent review of clinical trials for business purposes; Computer files managementSECTION 8 - CANCELLED—
042Scientific and technological services, research, consultancy, development and design, namely, clinical research in the field of cancer, oncological, neurological and inflammatory diseases; medical laboratory services; medical and scientific research, namely, conducting clinical trials for others and related advisory services; scientific laboratory services; analytical laboratory services, namely, laboratory research in the field of immunotherapy, histopathology, digital pathology, next generation immunohistochemistry, dna/mrna, fluorescence and silver in-situ hybridization, molecular pathology and all analytical methods covering morphological evaluation of specimens; scientific research for medical purposes in the area of cancerous diseases; providing information in the field of conducting clinical trials for others in the nature of scientific reports and reports related to scientific research and clinical tests; compiling data for research purposes in the field of medical science; providing medical and scientific research information in the field of clinical trials; genetic testing for scientific research purposes; design and development of computer softwareSECTION 8 - CANCELLED—
044Medical analysis services for the diagnosis of cancer, oncological, neurological and inflammatory diseases; medical analysis services, namely, medical testing for diagnostic or treatment purposes in the field of oncological, neurological and inflammatory diseases and immunotherapies; medical services in the field of pathology and tissue examination; RNA and DNA screening for cancer diagnosis and prognosisSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 28, 2025C8..CANCELLED SEC. 8 (6-YR)—
Sep 18, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 18, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 17, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 16, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 16, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 13, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 17, 2018IUAFUSE AMENDMENT FILED—
Jul 17, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 30, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 29, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 29, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 5, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 31, 2017ALIEASSIGNED TO LIE—
Oct 31, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 31, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 31, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 25, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2017DOCKASSIGNED TO EXAMINER—
Feb 1, 2017MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jan 31, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 31, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance